Učitavanje...
Denosumab could be a Potential Inhibitor of Valvular Interstitial Cells Calcification in vitro
OBJECTIVE: Denosumab is a fully human monoclonal antibody and novel antiresorptive agent that works by binding receptor activator of nuclear factor kappa-β ligand (RANKL) and inhibiting the signaling cascade that causes osteoclast maturation, activity, and survival. We aimed to elucidate the effect...
Spremljeno u:
| Izdano u: | Int J Cardiovasc Res |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2016
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4959558/ https://ncbi.nlm.nih.gov/pubmed/27468412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2324-8602.1000249 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|